Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capecitabine vs Gemcitabine plus Cisplatin in Resected Extrahepatic Cholangiocarcinoma
NCT03079427Phase 2Completed
- Sponsor
- Asan Medical Center
- Start
- May 2017
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine, cisplatin in extrahepatic cholangiocarcinoma (eCCA), sponsored by Asan Medical Center. Started May 2017; status: completed.
02
Drugs
gemcitabinecisplatin
03
Conditions
extrahepatic cholangiocarcinoma (eCCA)
Beyond the preview
Go deeper on NCT03079427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03079427.